The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 369 results:
Author [ Title(Asc)] Type Year
Filters: Author is Polyzos, Stergios A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
L
Papaefthymiou, A., Doulberis M., Polyzos S. A., Katsinelos P., Liatsos C., Koffas A., et al. (2020).  Letter: Helicobacter pylori in proton pump inhibitor-associated biliary disease.. Aliment Pharmacol Ther. 51(2), 313-314.
Moon, H-S., Dalamaga M., Kim S-Y., Polyzos S. A., Hamnvik O-P., Magkos F., et al. (2013).  Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals.. Endocr Rev. 34(3), 377-412.
Polyzos, S. A., Kountouras J., & Mantzoros C. S. (2015).  Leptin in nonalcoholic fatty liver disease: a narrative review.. Metabolism. 64(1), 60-78.
Polyzos, S. A., & Mantzoros C. S. (2015).  Leptin in health and disease: facts and expectations at its twentieth anniversary.. Metabolism. 64(1), 5-12.
Dalamaga, M., Chou S. H., Shields K., Papageorgiou P., Polyzos S. A., & Mantzoros C. S. (2013).  Leptin at the intersection of neuroendocrinology and metabolism: current evidence and therapeutic perspectives.. Cell Metab. 18(1), 29-42.
K
Kountouras, J., Chatzopoulos D., Zavos C., Deretzi G., Polyzos S. A., Gavalas E., et al. (2012).  Ki-67 and Bax expression in esophageal mucosa might have implications in ablative therapies for Barrett's esophagus, dysplasia, and adenocarcinoma.. Surg Endosc. 26(1), 283-4.
J
Polyzos, S. A., Cundy T., & Mantzoros C. S. (2018).  Juvenile Paget disease.. Metabolism. 80, 15-26.
I
Polyzos, S. A., Kountouras J., Anastasilakis A. D., Geladari E. V., & Mantzoros C. S. (2014).  Irisin in patients with nonalcoholic fatty liver disease.. Metabolism. 63(2), 207-17.
Polyzos, S. A., Kountouras J., & Anastasilakis A. D. (2021).  Irisin in nonalcoholic fatty liver disease: Need for an updated meta-analysis.. Metabolism. 121, 154818.
Polyzos, S. A., Anastasilakis A. D., Efstathiadou Z. A., Makras P., Perakakis N., Kountouras J., et al. (2018).  Irisin in metabolic diseases.. Endocrine. 59(2), 260-274.
Anastasilakis, A. D., Polyzos S. A., Makras P., Douni E., & Mantzoros C. S. (2019).  Irisin: good or bad for the bone? A new path forward after the reported discovery of irisin receptor?. Metabolism. 93, 100-102.
Polyzos, S. A., Mathew H., & Mantzoros C. S. (2015).  Irisin: A true, circulating hormone.. Metabolism. 64(12), 1611-8.
Polyzos, S. A., Kountouras J., Shields K., & Mantzoros C. S. (2013).  Irisin: a renaissance in metabolism?. Metabolism. 62(8), 1037-44.
Polyzos, S. A., Makras P., Efstathiadou Z., & Anastasilakis A. D. (2015).  Investigational parathyroid hormone receptor analogs for the treatment of osteoporosis.. Expert Opin Investig Drugs. 24(2), 145-57.
Polyzos, S. A., Duntas L., & Bollerslev J. (2017).  The intriguing connections of leptin to hyperparathyroidism.. Endocrine. 57(3), 376-387.
Sahin-Efe, A., Polyzos S. A., Dincer F., Zaichenko L., McGovern R., Schneider B., et al. (2015).  Intracellular leptin signaling following effective weight loss.. Metabolism. 64(8), 888-95.
Polyzos, S. A., Kountouras J., & Zavos C. (2009).  Insulin resistance and therapy: cross-talk between phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways.. Med Hypotheses. 72(5), 610.
Kountouras, J., Kazakos E., Kyrailidi F., Polyzos S. A., Zavos C., Arapoglou S., et al. (2023).  Innate immunity and nonalcoholic fatty liver disease.. Ann Gastroenterol. 36(3), 244-256.
Kountouras, J., Papaefthymiou A., Doulberis M., & Polyzos S. A. (2019).  Influence of Helicobacter pylori-connected metabolic syndrome on non-alcoholic fatty liver disease and its related colorectal neoplasm high risk.. Liver Int.
Papaefthymiou, A., Potamianos S., Goulas A., Doulberis M., Kountouras J., & Polyzos S. A. (2021).  Inflammatory Bowel Disease-associated Fatty Liver Disease: the Potential Effect of Biologic Agents.. J Crohns Colitis.
Polyzos, S. A., & Anastasilakis A. D. (2010).  Infectious thyroiditis as a complication of fine-needle biopsy: a systematic review.. Expert Rev Endocrinol Metab. 5(5), 673-679.
Polyzos, S. A., Zeglinas C., Artemaki F., Doulberis M., Kazakos E., Katsinelos P., et al. (2018).   infection and esophageal adenocarcinoma: a review and a personal view.. Ann Gastroenterol. 31(1), 8-13.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Vardaka E., Boziki M., Kyriakopoulos A., et al. (2021).  Impact of -related Microbial Dysbiosis in the Pathogenesis of Metabolic Syndrome and Gastrointestinal Dysmotility Disorders.. J Neurogastroenterol Motil. 27(4), 653-654.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Deretzi G., Vardaka E., Soteriades E. S., et al. (2021).  Impact of -Related Metabolic Syndrome Parameters on Arterial Hypertension.. Microorganisms. 9(11), 
Kountouras, J., Boziki M., Polyzos S. A., Katsinelos P., Gavalas E., Zeglinas C., et al. (2017).  Impact of reactive oxygen species generation on Helicobacter pylori-related extragastric diseases: a hypothesis.. Free Radic Res. 51(1), 73-79.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.